Form 4: Bio-Techne CEO Kim Kelderman Exercises Stock Options and Reports Beneficial Ownership
SEC Form 4 Filing
Kim Kelderman, CEO of Bio-Techne Corp, reports exercising stock options and discloses changes in beneficial ownership of company stock.
Summary
- On August 29, 2024, Kim Kelderman, the CEO of Bio-Techne Corp, executed a transaction involving company stock.
- Kelderman exercised stock options to acquire 1,492 shares of common stock at a price of $66.97 per share.
- Following the reported transaction, Kelderman's direct ownership includes 41,434 shares of common stock.
- Kelderman also holds various stock options and restricted stock units that vest at different dates and prices, extending to 2034.
- These holdings include options to purchase tens of thousands of shares at prices ranging from $37.7 to $120.46.
- Performance-based restricted stock units are also part of Kelderman's holdings, vesting based on the achievement of certain performance goals.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, so the sentiment is neither positive nor negative.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding the holdings and transactions of key company personnel.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- The vesting schedules and performance-based conditions are typical components of such compensation plans.
- Companies like Danaher, Thermo Fisher Scientific, and Agilent Technologies also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
- It can influence investor perception of management's alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 08/29/2024 | Date of transaction: Kim Kelderman exercised stock options. |
| 09/03/2024 | Date of report filing. |
| 05/01/2025 | Expiration date for some stock options. |
| 08/08/2025 | Expiration date for some stock options. |
| 08/07/2026 | Expiration date for some stock options. |
| 08/05/2027 | Expiration date for some stock options. |
| 08/06/2028 | Expiration date for some stock options. |
| 08/15/2029 | Expiration date for some stock options. |
| 08/15/2030 | Expiration date for some stock options. |
| 11/01/2030 | Expiration date for some stock options. |
| 02/01/2031 | Expiration date for some stock options. |
| 08/15/2034 | Expiration date for some stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.